Trials / Completed
CompletedNCT03868163
Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation
Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 161 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study seeks to assess the effectiveness of Glecaprevir plus Pibrentasvir in participants with chronic hepatitis C in a real-life setting across clinical practice populations in the Russian Federation.
Conditions
Timeline
- Start date
- 2019-02-28
- Primary completion
- 2020-09-04
- Completion
- 2020-09-04
- First posted
- 2019-03-08
- Last updated
- 2021-08-30
Locations
9 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT03868163. Inclusion in this directory is not an endorsement.